z-logo
open-access-imgOpen Access
Randomized, Double-Blind, Multicenter Phase 2 Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia Suspected or Confirmed Caused by Gram-Positive Pathogens
Author(s) -
David B. Huang,
Mark Wilcox,
Paul Hadváry,
Ralph Corey
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.608
Subject(s) - medicine , vancomycin , pneumonia , ventilator associated pneumonia , intensive care medicine , randomized controlled trial , data monitoring committee , emergency medicine , staphylococcus aureus , biology , bacteria , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom